Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

BusinessWeek March 4, 2010 Frederik Balfour	The Ka-Ching in China Luring Medical Giants GE, Siemens, and others are angling for a piece of the $125 billion Beijing plans to spend on health care.
The Motley Fool August 5, 2010 Tim Hanson	Our Best Ideas From China Here's how you can ride a rising wave of Chinese consumerism.
The Motley Fool September 28, 2007 Timothy M. Otte	Foolish Forecast: Walgreen Still Minting the Green? In advance of fourth-quarter earnings, analysts expect the company to continue its record of four straight years of sales growth.
The Motley Fool July 6, 2009 Nathan Parmelee	China's Getting Old Fast According to an article in last week's The Economist, which references United Nations data on aging trends, China can expect to see an ever-greater portion of retirees dominate its population. And health-care spending should soar.
The Motley Fool March 16, 2007 Bill Mann	iRobot vs. New Oriental Education: New Oriental Education In honor of the annual NCAA College Basketball Tournament, a.k.a. March Madness -- here is "Stock Madness 2007." This is a hot sector in a hot market.
The Motley Fool January 7, 2010 Gerard Torres	Walgreen Lives to Fight Another Day Despite recent success, Walgreen continues to face stiff competition.
Finance & Development September 2010 Steve Barnett	Building a Social Safety Net China embarks on an effort to improve both pensions and health care in the world's most populous nation
The Motley Fool March 30, 2011 Sean Williams	China Clamps Down on Drug Manufacturers These drug manufacturers could be feeling a pinch from new Chinese price caps.
The Motley Fool February 12, 2010 Tim Hanson	This Is Still a Great Place to Invest I've said it before, and I'll say it again. When I tell people I'm buying stocks in China, I get shocked stares.
The Motley Fool May 8, 2007 Ryan Fuhrmann	CVS/Caremark Tie the Knot While it's too early to see if CVS blazed a new health-care trail by combining a drugstore chain with giant pharmacy benefit manager Caremark, there are still interesting tidbits to pass along to investors from recently reported results.
The Motley Fool July 27, 2004 Brian Gorman	Medco's Pumped About Generics Generic drugs are actually helping improve Medco's margins, making it a winner with investors and health-care plans.
CFO September 1, 2009 Edward Teach	"This Is the Future." A drugstore giant now offers walk-in health-care clinics. An interview with Wade D. Miquelon, CFO and executive vice president, Walgreen Co.
The Motley Fool March 5, 2009 Brian Orelli	5 Stocks to Benefit From China's Health-Care Plan Same idea, different country.
The Motley Fool March 26, 2010 Cathy Applefeld Olson	Can CVS Caremark Win the Drug Wars? Now that health-care legislation has been signed into law, it's a perfect time to give the country's largest drugstore chain a checkup.
The Motley Fool August 15, 2005 Bobby Shethia	Walgreen's Prescription for Success The drugstore chain's smart and steady growth makes it a good choice for investors.
CRM November 1, 2007 Woody Driggs	The Year (and Decade) of the Tiger Think you can translate your brand for the savvy Chinese shopper?
The Motley Fool June 30, 2009 Tim Hanson	3 China Profit Plays The obvious ways to make money in the world's most important emerging market.
The Motley Fool August 25, 2009 Jennifer Schonberger	7 Health-Care Stocks to Nurse Your Portfolio As fears about the health-care bill abate, valuations in the sector look ripe.
The Motley Fool February 5, 2008 Will Frankenhoff	3 Reasons to Stay in Chinese Stocks in 2008 The recent savage sell-off in Chinese stocks -- the Shanghai index has fallen more than 13% since the beginning of the year -- may represent a buying opportunity.
The Motley Fool June 22, 2007 Tim Hanson	Double the Market's Return Investors, if you don't know about New Oriental Education, you should. It's the leading provider of English education in China; and yet, with less than 300,000 current students, it has tremendous upside potential with just 3% market share.
The Motley Fool February 2, 2007 Ryan Fuhrmann	Uncertain Outlook on CVS Has the retail pharmacy bit off more than it can chew? Investors may soon look back longingly to the day when CVS focused as much on organic, or internal, means to grow its business as it does on acquisitions to buy outside market share.
The Motley Fool November 2, 2006 Ryan Fuhrmann	CVS Blazes a New Healthcare Trail Strong third-quarter earnings aside, the merger announcement with pharmacy benefit manager Caremark was the real shocker here. Investors, take note.
The Motley Fool August 1, 2007 Ryan Fuhrmann	Foolish Forecast: CVS Caremark Gets Ready to Rumble CVS Caremark will announce its first combined quarterly results tomorrow. Competitors will be watching to see if the merger of drugstore chain and pharmacy benefit manager is a healthy one.
The Motley Fool February 23, 2009 Brian Bauer	4 Stocks for Scaredy-Cats Cautious investors -- let's call them the scaredy-cats -- think the economy might take longer to recover than many expect. Here are four stocks for them: Johnson & Johnson... PepsiCo... McDonald's... CVS Caremark...
The Motley Fool January 8, 2007 Will Frankenhoff	3 Reasons to Stay Long Chinese Stocks in 2007 There still may be gut-wrenching moments where investors feel like throwing in the proverbial towel, but the trend is clear: Stay long and strong Chinese equities. A little pain might yield a lot of gain.
The Motley Fool June 29, 2010 Tim Hanson	The Stock I Want to Buy in China Which one do you want?
The Motley Fool May 18, 2007 Timothy M. Otte	Longs Drug Scores a Winner The West Coast retail drug chain expands its gross margin and beats analyst estimates.
The Motley Fool October 7, 2010	DRIP Portfolio Candidate: Walgreen Why this nationally known drugstore should make it into your DRIP portfolio.
The Motley Fool January 3, 2005 Nathan Slaughter	Walgreen Seeing Green Rivals CVS and Rite Aid have a bitter pill to swallow as Walgreen stays strong. While Walgreen's revenues were in line with forecasts, the stronger-than-expected bottom line has the stock gaining ground.
The Motley Fool October 1, 2008 Timothy M. Otte	Walgreen Passes Q4 Physical Slower growth doesn't slow down drugstore giant Walgreen's.
The Motley Fool January 12, 2009 Brian Orelli	Trust Management or Don't Buy American Oriental Bioengineering, purveyor of traditional Chinese medical products, bought a $70 million building to use as a "Convention and Training Center," and investors aren't happy about it.
The Motley Fool August 3, 2007 Ryan Fuhrmann	CVS Caremark Is No Sicko Pharmacy powerhouse CVS Caremark is looking to blaze a new health-care trail with the recent merger of their drugstore and pharmacy benefit management operations.
The Motley Fool December 2, 2010 Tim Hanson	Our Top Chinese Consumer Play Why aren't more people looking at China Mass Media?
The Motley Fool June 30, 2011 David Williamson	Pharmacy Benefits Delivering Drama CVS claims another Medco client and one messy split.
The Motley Fool October 2, 2007 Lawrence A. Rothman	Can the Right Prescription Heal Walgreen? Walgreen is suffering from heightened competition, expenses rising more than 11%, and the company itself predicting its challenges will probably continue into the near future.
The Motley Fool March 18, 2010 Rex Moore	The Danger of Overpaying for These Stocks China's where the growth is, but the bargains are not where you'd expect.
The Motley Fool November 9, 2006 Mike Norman	CVS-Caremark Not So Hard to Swallow Huge demographic and policy trends are likely to make this match a winner. Why did investors sell CVS?
The Motley Fool April 1, 2010 Tim Hanson	Chill Out About China's Currency Why Paul Krugman, Congress, and others should let China's currency revaluation take time.
Financial Planning January 1, 2011 Christopher I. Franklin	Winner's Circle Without a winner's circle in leadership, an advisory practice will lag behind its peers. Building a winner's circle is just as important to your success as market resurgence.
The Motley Fool October 31, 2008 Timothy M. Otte	CVS Caremark Takes Care of Its Investors The drugstore giant continues to scoop up market share.
The Motley Fool June 10, 2010 Claire Stephanic	CVS Caremark vs. Walgreen The two go head-to-head in competition for pharmacy customers.
The Motley Fool December 10, 2010 Tim Hanson	A Massive Bubble and an Incredible Buying Opportunity In fact, they are one and the same thing. The IPO calendar here in the U.S. has been dominated by Chinese companies in recent months.
The Motley Fool November 5, 2007 Timothy M. Otte	CVS Is in the Zone Pharmacy giant CVS grew EPS by 36% in the third quarter. The company has been on a roll since its merger with Caremark last year.
The Motley Fool June 14, 2010 Rich Smith	Is CVS' $2 Billion Buyback Good Medicine? Don't assume just because CVS is buying its stock, that this is a good idea.
The Motley Fool October 27, 2005 Stephen D. Simpson	Can ESRX Spell P-r-o-f-i-t-s? A company focused on lowering medical costs sounds like a good idea, but investors should dig deeper. While pharmaceutical benefits manager Express Scripts offers high growth and high valuation, it may also offer higher-than-average risk.
The Motley Fool December 21, 2007 Timothy M. Otte	Walgreen Shapes Up for 2008 The drugstore chain reports lower expenses in the first quarter while pumping up sales.
The Motley Fool July 28, 2010 Nate Weisshaar	Graying Dragon Can China get rich before it gets old? Just hitching your wagon to anything Chinese won't work anymore, and like the more mature markets most U.S. investors are familiar with, stock selection will become the key to solid returns.
The Motley Fool March 26, 2007 Ryan Fuhrmann	Addicted to Growth at Walgreen Walgreen is a steady grower, but that comes at a price. Investors, take note.
BusinessWeek November 11, 2010	Steven Romick: Volatility Into Opportunity FPA Crescent Fund's Romick sees Aon, Oxy, and CVS as outperforming the market.
IndustryWeek July 1, 2007 Thomas J. Duesterberg	The Competitive Edge -- China's Day Of Reckoning Is Coming Soon Some clouds are beginning to form on the horizon of China's growth model.